ROBERT COMIS, professor of medicine at Drexel University, will step down from his position as group co-chair of ECOG-ACRIN Cancer Research Group. His departure, effective Feb. 28, 2019, will coincide with the end of ECOG-ACRIN’s current National Clinical Trials Network Operations Center U10 grant award from the NCI. Comis chaired the Eastern Cooperative Oncology Group...
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
